Latest News

Intranasal ketamine confers rapid antidepressant effect in depression

The first controlled evidence has been released showing that an intranasal ketamine spray conferred an unusually rapid antidepressant effect ?- within 24 hours ?- and was well tolerated in patients with treatment-resistant major depressive disorder. One of the most common NMDA receptor antagonists, ketamine is an FDA-approved anesthetic. It has been used in animals and humans for years. Ketamine has also been a drug of abuse and can lead to untoward psychiatric or cognitive problems when misused. In low doses, ketamine shows promise in providing rapid relief of depression, with tolerable side effects.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Why your brain makes you reach for junk food

  • See-through sensors open new window into the brain

  • New test to help brain injury victims recover

  • Fish intake associated with boost to antidepressant response

  • Head injury causes immune system to attack brain, new study finds

  • Design of micro, nanoparticles to improve treatments for Alzheimer's, Parkinson's

  • New antidepressant: Rapid agent restores pleasure-seeking ahead of other antidepressant action

  • Brain activity provides evidence for internal 'calorie counter'

  • Sport in old age can stimulate brain fitness, but effect decreases with advancing age

  • I have anxiety, why is my doctor prescribing an antipsychotic? New drug naming system unveiled

  •